Endocrine Pathology

Aims & Scope

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders.

Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology.

Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques.

Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication.

Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher.

All articles are subject to review by experienced referees.

The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	14.7
2024	11.30

Journal Rank

Year	Value
2024	468

Journal Citation Indicator

Year	Value
2024	1404

SJR (SCImago Journal Rank)

Year	Value
2024	3.832

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	61

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Overview of the 2022 WHO Classification of Thyroid Neoplasms

  Citation: 816

  Authors: Zubair W., Sylvia L., Justine A., Ronald A., C. Christofer, Chan Kwon, Virginia A., Mauro G., Manuel, Giovanni, Ozgur

• Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

  Citation: 653

  Authors: Guido, Ozgur, Silvia, Olca, Stefano, Lodewijk A. A., Shereen, Wouter W., David S., Mauro, Sylvia L.

• Overview of the 2022 WHO Classification of Pituitary Tumors

  Citation: 400

  Authors: Sylvia L., Ozgur, Arie, Robert Y.

• Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours

  Citation: 365

  Authors: Alfred King-yin

• RET/PTC Rearrangement in Thyroid Tumors

  Citation: 364

  Authors: Yuri E

• Overview of the 2017 WHO Classification of Pituitary Tumors

  Citation: 353

  Authors: Ozgur, M. Beatriz

• Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

  Citation: 287

  Authors: Ozgur, Sylvia L., Anthony J., Noriko, Ronald R., Arthur

• Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

  Citation: 215

  Authors: Ozgur, Lori A., C. Christofer, Ronald R., Hironobu, Marco, Mauro G.

• The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas

  Citation: 190

  Authors: Hiroshi, Naoko, Ozgur, Sylvia L., Kyohei, Akira, Noriaki, Mitsuo, Yasuhiro, Shozo

• Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms

  Citation: 189

  Authors: Stefano, Fausto, Silvia

---